Literature DB >> 25366277

Multiplex RT-PCR and indirect immunofluorescence assays for detection and subtyping of human influenza virus in Tunisia.

Manel Ben M'hadheb1, Myriam Harrabi, Amira Souii, Nadia Jrad-Battikh, Jawhar Gharbi.   

Abstract

Influenza viruses are negative stranded segmented RNA viruses belonging to Orthomyxoviridae family. They are classified into three types A, B, and C. Type A influenza viruses are classified into subtypes according to the antigenic characters of the surface glycoproteins: hemagglutinin (H) and neuraminidase (N). The aim of the present study is to develop a fast and reliable multiplex RT-PCR technique for detecting simultaneously the subtypes A/H1N1 and A/H3N2 of influenza virus. Our study included 398 patients (mean age 30.33 ± 19.92 years) with flu or flu-like syndromes, consulting physicians affiliated with collaborating teams. A multiplex RT-PCR detecting A/H1N1 and A/H3N2 influenza viruses and an examination by indirect immunofluorescence (IFI) were performed. In the optimized conditions, we diagnosed by IFI a viral infection in 90 patients (22.6 %): 85 cases of influenza type A, four cases of influenza type B, and only one case of coinfection with types A and B. An evaluation of the technique was performed on 19 clinical specimens positive in IFI, and we detected eight cases of A/H3N2, five cases of A/H1N1, one case of influenza virus type A which is not an H1N1 nor H3N2, and five negative cases. Multiplex RT-PCR is a sensitive technique allowing an effective and fast diagnosis of respiratory infections caused by influenza viruses in which the optimization often collides with problems of sensibility.

Entities:  

Mesh:

Year:  2014        PMID: 25366277     DOI: 10.1007/s00284-014-0719-0

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  20 in total

1.  Comparison of the BD Directigen Flu A+B Kit and the Abbott TestPack RSV with a multiplex RT-PCR ELISA for rapid detection of influenza viruses and respiratory syncytial virus.

Authors:  B Gröndahl; W Puppe; J Weigl; H-J Schmitt
Journal:  Clin Microbiol Infect       Date:  2005-10       Impact factor: 8.067

2.  Comparison of a multiplex reverse transcription-PCR-enzyme hybridization assay with conventional viral culture and immunofluorescence techniques for the detection of seven viral respiratory pathogens.

Authors:  L Liolios; A Jenney; D Spelman; T Kotsimbos; M Catton; S Wesselingh
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

3.  Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996.

Authors:  J S Ellis; D M Fleming; M C Zambon
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

4.  Universal primer set for the full-length amplification of all influenza A viruses.

Authors:  E Hoffmann; J Stech; Y Guan; R G Webster; D R Perez
Journal:  Arch Virol       Date:  2001-12       Impact factor: 2.574

5.  Rapid diagnosis of human parainfluenza virus type 1 infection by quantitative reverse transcription-PCR-enzyme hybridization assay.

Authors:  J Fan; K J Henrickson
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

6.  Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults.

Authors:  J A Englund; P A Piedra; A Jewell; K Patel; B B Baxter; E Whimbey
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

7.  Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility study.

Authors:  B Gröndahl; W Puppe; A Hoppe; I Kühne; J A Weigl; H J Schmitt
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

8.  Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia.

Authors:  Leontine J R van Elden; Marian G J van Kraaij; Monique Nijhuis; Karin A W Hendriksen; Ad W Dekker; Maja Rozenberg-Arska; Anton M van Loon
Journal:  Clin Infect Dis       Date:  2001-12-04       Impact factor: 9.079

9.  Type-specific identification of influenza viruses A, B and C by the polymerase chain reaction.

Authors:  E C Claas; M J Sprenger; G E Kleter; R van Beek; W G Quint; N Masurel
Journal:  J Virol Methods       Date:  1992-09       Impact factor: 2.014

10.  [Diagnosis and epidemiological surveillance of influenza and respiratory syncytial virus infections: interest of multiplex PCR].

Authors:  C Plouzeau; M Paccalin; A Beby-Defaux; G Giraudeau; C Godet; G Agius
Journal:  Med Mal Infect       Date:  2007-06-08       Impact factor: 2.152

View more
  4 in total

1.  Epidemiology and clinical profile of pathogens responsible for the hospitalization of children in Sousse area, Tunisia.

Authors:  Ines Brini; Aida Guerrero; Naila Hannachi; Jihene Bouguila; Dorothea Orth-Höller; Amira Bouhlel; Lamia Boughamoura; Benjamin Hetzer; Wegene Borena; Britta Schiela; Dorothee Von Laer; Jalel Boukadida; Heribert Stoiber
Journal:  PLoS One       Date:  2017-11-17       Impact factor: 3.240

2.  The epidemiology of seasonal influenza after the 2009 influenza pandemic in Africa: a systematic review.

Authors:  Adamou Lagare; Soatiana Rajatonirina; Jean Testa; Saidou Mamadou
Journal:  Afr Health Sci       Date:  2020-12       Impact factor: 0.927

3.  Clinical and epidemiological characteristics of influenza virus infection in hospitalized children with acute respiratory infections in Sri Lanka.

Authors:  Rukshan A M Rafeek; Maduja V M Divarathna; Adrian J Morel; Faseeha Noordeen
Journal:  PLoS One       Date:  2022-09-02       Impact factor: 3.752

4.  Phylogenetic analysis of the neuraminidase segment gene of Influenza A/H1N1 strains isolated from Monastir Region (Tunisia) during the 2017-2018 outbreak.

Authors:  Sabrine Ben Hamed; Aida Elargoubi; Myriam Harrabi; Haythem Srihi; Oussema Souiai; Maha Mastouri; Mohammed Awadh Almalki; Jawhar Gharbi; Manel Ben M'hadheb
Journal:  Biologia (Bratisl)       Date:  2021-03-12       Impact factor: 1.350

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.